These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31441705)

  • 21. Comparative phenotypic and genotypic analysis of community-acquired and hospital-acquired intra-abdominal infections among liver transplanted patients.
    Elmanakhly AR; Safwat N; Tohamy STK; Elsayed KM; ElSherif HM; Elsayed M; El-Tarabili RM; Alhomrani M; Alamri AS; Ghoneim MM; Alshahrani MA; Saif A; Mansour AT; Bendary MM
    J Appl Microbiol; 2024 Apr; 135(4):. PubMed ID: 38515285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics and antimicrobial patterns in complicated intra-abdominal infections: a 6-year epidemiological study in southern China.
    Ouyang W; Xue H; Chen Y; Gao W; Li X; Wei J; Wen Z
    Int J Antimicrob Agents; 2016 Mar; 47(3):210-6. PubMed ID: 26899413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critically ill patients with community-onset intraabdominal infections: Influence of healthcare exposure on resistance rates and mortality.
    Maseda E; Ramírez S; Picatto P; Peláez-Peláez E; García-Bernedo C; Ojeda-Betancur N; Aguilar G; Forés B; Solera-Marín J; Aliaño-Piña M; Tamayo E; Ramasco F; García-Álvarez R; González-Lisorge A; Giménez MJ; Suárez-de-la-Rica A;
    PLoS One; 2019; 14(9):e0223092. PubMed ID: 31557256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.
    Mehl A; Åsvold BO; Kümmel A; Lydersen S; Paulsen J; Haugan I; Solligård E; Damås JK; Harthug S; Edna TH
    BMC Infect Dis; 2017 Feb; 17(1):116. PubMed ID: 28148226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does microbial resistance profile change in community-based intra-abdominal infections? Evaluation of the culture results of patients with appendicitis.
    Tartar T; Sağmak-Tartar A; Saraç M; Bakal Ü; Akbulut A; Kazez A
    Turk J Pediatr; 2018; 60(5):520-526. PubMed ID: 30968625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Microbiological and resistance profiles of community acquired and nosocomial intra abdominal infections in surgery of National Hospital Guillermo Almenara, Lima, Peru].
    Revoredo Rego F; Huamán Egoávil E; Zegarra Cavani S; Auris Mora H; Valderrama Barrientos R
    Rev Gastroenterol Peru; 2016; 36(2):115-22. PubMed ID: 27409087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogen Prevalence and Antimicrobial Susceptibility Among Enterobacteriaceae Causing Hospital-associated Intra-abdominal Infections in Adults in the United States (2012-2013).
    Zalacain M; Biedenbach DJ; Badal RE; Young K; Motyl M; Sahm DF
    Clin Ther; 2016 Jun; 38(6):1510-1521. PubMed ID: 27234360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Community-acquired complicated intra-abdominal infections in children hospitalized during 1995-2004 at a paediatric surgery department.
    Newman N; Wattad E; Greenberg D; Peled N; Cohen Z; Leibovitz E
    Scand J Infect Dis; 2009; 41(10):720-6. PubMed ID: 19681021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017).
    Cantón R; Loza E; Aznar J; Castillo FJ; Cercenado E; Fraile-Ribot PA; González-Romo F; López-Hontangas JL; Rodríguez-Lozano J; Suárez-Barrenechea AI; Tubau F; Díaz-Regañón J; López-Mendoza D;
    Rev Esp Quimioter; 2019 Apr; 32(2):145-155. PubMed ID: 30761824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does Isolation of Enterococcus Affect Outcomes in Intra-Abdominal Infections?
    Sanders JM; Tessier JM; Sawyer R; Dellinger EP; Miller PR; Namias N; West MA; Cook CH; O'Neill PJ; Napolitano L; Rattan R; Cuschieri J; Claridge JA; Guidry CA; Askari R; Banton K; Rotstein O; Moore BJ; Duane TM
    Surg Infect (Larchmt); 2017; 18(8):879-885. PubMed ID: 28994635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
    Zhang H; Yang Q; Liao K; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Chu Y; Chen S; Cao B; Su J; Duan Q; Zhang S; Shao H; Kong H; Gui B; Hu Z; Badal R; Xu Y
    BMC Infect Dis; 2017 Dec; 17(1):776. PubMed ID: 29254478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospital-associated intra-abdominal infections in China.
    Yang Q; Zhang H; Wang Y; Xu Y; Chen M; Badal RE; Wang H; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Hu Y; Ye H
    J Med Microbiol; 2013 Sep; 62(Pt 9):1343-1349. PubMed ID: 23741022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam.
    Popejoy MW; Long J; Huntington JA
    BMC Infect Dis; 2017 May; 17(1):316. PubMed ID: 28464828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the aerobic faecal flora of patients treated with antibiotics for acute intra-abdominal infection.
    Samuelsson A; Isaksson B; Chabok A; Jonasson J; Nilsson LE; Eriksson O; Hanberger H
    Scand J Infect Dis; 2012 Nov; 44(11):820-7. PubMed ID: 22831634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological study of community- and hospital-acquired intraabdominal infections.
    Zhang S; Huang W
    Chin J Traumatol; 2015; 18(2):84-9. PubMed ID: 26511299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).
    Solomkin J; Hershberger E; Miller B; Popejoy M; Friedland I; Steenbergen J; Yoon M; Collins S; Yuan G; Barie PS; Eckmann C
    Clin Infect Dis; 2015 May; 60(10):1462-71. PubMed ID: 25670823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical challenges and unmet needs in the management of complicated intra-abdominal infections.
    Mazuski JE
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-49-69. PubMed ID: 23577497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of Five Antibiotic Regimens for the Treatment of Intra-Abdominal Infection in Bogotá.
    López GAM; Rodríguez LFC; Fandiño LCS; Lasso AD; Granados JPA; Salazar YID; Pereira KA; Velásquez JP; Luna JAC; Trujillo CHS
    Surg Infect (Larchmt); 2022 Dec; 23(10):933-939. PubMed ID: 36472509
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of body mass index on treatment of complicated intra-abdominal infections in hospitalized adults: comparison of ertapenem with piperacillin-tazobactam.
    Zakrison TL; Hille DA; Namias N
    Surg Infect (Larchmt); 2012 Feb; 13(1):38-42. PubMed ID: 22217196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility to antibiotics of aerobic bacteria isolated from community acquired secondary peritonitis in children: therapeutic guidelines might not always fit with and everyday experience.
    Castagnola E; Bandettini R; Ginocchio F; Perotti M; Masa DL; Ciucci A; Loy A; Caviglia I; Haupt R; Guida E; Pini Prato A; Mattioli G; Buffa P
    J Chemother; 2013 Aug; 25(4):213-6. PubMed ID: 23906074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.